Posts

Top 30 Objectionable Microorganisms in Pharmaceutical Products: FDA Expectations, USP Requirements & GMP Risk Assessment (2026)

Image
PHARMACEUTICAL MICROBIOLOGY | GMP | FDA Top 30 Objectionable Microorganisms in Pharmaceutical Products: FDA Expectations, USP Requirements & GMP Risk Assessment (2026) Understand the 30 microorganisms of potential pharmaceutical concern, identify contamination risks, interpret FDA expectations and develop a practical objectionable microorganism risk assessment for non-sterile pharmaceutical products. Technical guide | Updated November 2026 | Reading time: Approximately 12–15 minutes Inspection warning: Your TAMC and TYMC results are within specification. However, an FDA investigator asks: "How do you demonstrate that microorganisms recovered from your pharmaceutical product are not objectionable?" Can your microbiology laboratory provide a scientifically justified answer? Microbial limits testing is not simply about obtaining counts within established acceptance criteria. Pharmaceutical manufacturers must understand which microorganisms may adversely a...

Top 10 Pharmaceutical Microbial Contamination Disasters in History (2026): FDA Findings, GMP Failures & Lessons for Pharma Professionals

PHARMACEUTICAL MICROBIOLOGY | GMP | PATIENT SAFETY Top 10 Pharmaceutical Microbial Contamination Disasters in History (2026): FDA Findings, GMP Failures and Lessons for Pharma Professionals A single contaminated vial, a failed sterilisation cycle or an uncontrolled microbial source can create a serious patient-safety event. Discover ten important historical cases, the organisms involved, the failures identified and the contamination-control lessons every pharmaceutical professional should understand. Historical Case Studies GMP Investigation FDA & CDC 2026 Reference Guide What happens when a product labelled sterile reaches a patient with viable microorganisms inside it? History shows that the consequences can include bloodstream infections, meningitis, permanent vision loss, product recalls and major regulatory action. Pharmaceutical microbial contamination is not simply a laboratory failure. It is a potential breakdown of the entire contamination-cont...

Popular posts from this blog

Difference Between Equipment and Instrument in Pharmaceutical Industry (Definitions, GMP Examples & Audit Risks)

Alert and Action Limits in Environmental Monitoring: GMP Meaning, Differences & Best Practices

NVPC in Pharma: Full Form, Limits, Guidelines & Non-Viable Particle Count

TNTC vs TFTC in Microbiology: Meaning, CFU Calculation, Countable Range & GMP Guide (2026)

How to Calculate Log Reduction in Pharmaceutical Microbiology: Step-by-Step Guide with Examples